Acacia Pharma Group plc, of Cambridge, U.K., appointed Gary Gemignani chief financial officer and Anne-Marie Elsley company secretary. Scott Byrd will be appointed chair of the board at the annual general meeting.
BC Platforms AG, of Zurich, Switzerland, appointed Karen Tay Koh to its board.
Generex Biotechnology Corp., of Miramar, Fla., appointed S. Gail Eckhardt to the board of Nugenerex Immuno-Oncology.
Ovid Therapeutics Inc., of New York, appointed Alexander Kolevzon to its scientific advisory board.